Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hafner

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|December 17, 2008
Transcriptional co-activator peroxisome proliferator-activated receptor (PPAR)gamma co-activator-1beta is involved in the regulation of glucose-stimulated insulin secretion in INS-1E cellsHannes Oberkofler, Michael Hafner, Thomas Felder, et al.
Scientific Reports|June 20, 2025
Quantitative comparison of a novel swept-source optical coherence tomography angiography device with three established systemsMichael Hafner, Siegfried G Priglinger, Bettina von Livonius, et al.
Plos One|February 27, 2026
Quantifying segmentation sensitivity in OCTA: Device-specific profiles across three commercial platformsMichael Hafner, Bettina von Livonius, Daniel Deschler, et al.
Ophthalmology and Therapy|March 26, 2025
Deep-Learning-Assisted Analysis of Early Biomarker Changes in Treatment-Naïve Patients with Neovascular AMD Under Intravitreal FaricimabMichael Hafner, Ben Asani, Franziska Eckardt, et al.
Plos One|September 29, 2021
Anti-inflammatory activity of lefamulin versus azithromycin and dexamethasone in vivo and in vitro in a lipopolysaccharide-induced lung neutrophilia mouse modelMichael Hafner, Susanne Paukner, Wolfgang W Wicha, et al.
Journal of Clinical Medicine|October 29, 2025
Extended Real-World Efficacy of Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: 9-Month Follow-Up ResultsMichael Hafner, Tina R Herold, Alexander Kufner, et al.
BMC Ophthalmology|November 13, 2025
Quantitative comparison of a novel wide-field OCT-angiography device with ultrawide-field fluorescein angiography in detecting retinal nonperfusion in vascular retinopathiesMichael Hafner, Tina R Herold, Viktoria Deiters, et al.
Diagnostics (Basel, Switzerland)|March 14, 2026
Quantitative Comparison of Two Novel Swept-Source Optical Coherence Tomography Angiography DevicesMichael Hafner, Daniel J P Deschler, Alexander Kufner, et al.
Journal of Clinical Medicine|April 12, 2025
Switching to Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: Initial Real-World Efficacy OutcomesMichael Hafner, Tina R Herold, Alexander Kufner, et al.
BMJ Open Ophthalmology|June 1, 2025
Deep learning-assisted analysis of biomarker changes after increase of dosing from aflibercept 2 mg to 8 mg in therapy-resistant neovascular age-related macular degenerationMichael Hafner, Ben Asani, Franziska Eckardt, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Molecular Medicine (Berlin, Germany)|December 17, 2008
Transcriptional co-activator peroxisome proliferator-activated receptor (PPAR)gamma co-activator-1beta is involved in the regulation of glucose-stimulated insulin secretion in INS-1E cellsHannes Oberkofler, Michael Hafner, Thomas Felder, et al.
Scientific Reports|June 20, 2025
Quantitative comparison of a novel swept-source optical coherence tomography angiography device with three established systemsMichael Hafner, Siegfried G Priglinger, Bettina von Livonius, et al.
Plos One|February 27, 2026
Quantifying segmentation sensitivity in OCTA: Device-specific profiles across three commercial platformsMichael Hafner, Bettina von Livonius, Daniel Deschler, et al.
Ophthalmology and Therapy|March 26, 2025
Deep-Learning-Assisted Analysis of Early Biomarker Changes in Treatment-Naïve Patients with Neovascular AMD Under Intravitreal FaricimabMichael Hafner, Ben Asani, Franziska Eckardt, et al.
Plos One|September 29, 2021
Anti-inflammatory activity of lefamulin versus azithromycin and dexamethasone in vivo and in vitro in a lipopolysaccharide-induced lung neutrophilia mouse modelMichael Hafner, Susanne Paukner, Wolfgang W Wicha, et al.
Journal of Clinical Medicine|October 29, 2025
Extended Real-World Efficacy of Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: 9-Month Follow-Up ResultsMichael Hafner, Tina R Herold, Alexander Kufner, et al.
BMC Ophthalmology|November 13, 2025
Quantitative comparison of a novel wide-field OCT-angiography device with ultrawide-field fluorescein angiography in detecting retinal nonperfusion in vascular retinopathiesMichael Hafner, Tina R Herold, Viktoria Deiters, et al.
Diagnostics (Basel, Switzerland)|March 14, 2026
Quantitative Comparison of Two Novel Swept-Source Optical Coherence Tomography Angiography DevicesMichael Hafner, Daniel J P Deschler, Alexander Kufner, et al.
Journal of Clinical Medicine|April 12, 2025
Switching to Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: Initial Real-World Efficacy OutcomesMichael Hafner, Tina R Herold, Alexander Kufner, et al.
BMJ Open Ophthalmology|June 1, 2025
Deep learning-assisted analysis of biomarker changes after increase of dosing from aflibercept 2 mg to 8 mg in therapy-resistant neovascular age-related macular degenerationMichael Hafner, Ben Asani, Franziska Eckardt, et al.
Pageof 2